Neonatal Dengue With HLH: Perks of Early Diagnosis and Management

J Pediatr Hematol Oncol. 2021 Aug 1;43(6):e770-e773. doi: 10.1097/MPH.0000000000001881.

Abstract

Background: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening, aggressive syndrome. It can be primary, which involves genetic mutation with an early presentation, or secondary to infections, malignancies, etc., due to absence of immune downregulation. It is a very rare condition in newborns. Dengue is a potential virus causing HLH, but, in newborns, there are only few case reports and limited clinical literature.

Observation: Herein, in this report, we highlight a case of neonatal HLH, triggered by perinatal dengue. The neonate manifested clinically within the first week of life, the earliest reported timeline so far in the literature.

Conclusion: HLH should be excluded in neonates especially when multisystem involvement cannot be explained by sepsis alone.

Publication types

  • Case Reports

MeSH terms

  • Dengue / complications*
  • Dengue / diagnosis
  • Dengue / therapy
  • Dengue Virus / isolation & purification
  • Disease Management
  • Early Diagnosis
  • Humans
  • Infant, Newborn
  • Lymphohistiocytosis, Hemophagocytic / diagnosis
  • Lymphohistiocytosis, Hemophagocytic / etiology*
  • Lymphohistiocytosis, Hemophagocytic / therapy
  • Male